GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q2 2019. The put-call ratio across all filers is 145.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $65,000 | -19.8% | 21,596 | +0.3% | 0.00% | – |
| Q4 2020 | $81,000 | +19.1% | 21,539 | -2.8% | 0.00% | – |
| Q3 2020 | $68,000 | -12.8% | 22,157 | +7.1% | 0.00% | – |
| Q2 2020 | $78,000 | +69.6% | 20,694 | +3.4% | 0.00% | – |
| Q1 2020 | $46,000 | -58.9% | 20,020 | -5.5% | 0.00% | – |
| Q4 2019 | $112,000 | +21.7% | 21,176 | -0.8% | 0.00% | – |
| Q3 2019 | $92,000 | -64.1% | 21,354 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $256,000 | -5.5% | 21,504 | -1.0% | 0.00% | 0.0% |
| Q1 2019 | $271,000 | +27.8% | 21,721 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $212,000 | -34.8% | 22,425 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $325,000 | -7.9% | 22,598 | +3.2% | 0.00% | 0.0% |
| Q2 2018 | $353,000 | +908.6% | 21,902 | +243.3% | 0.00% | – |
| Q1 2017 | $35,000 | -2.8% | 6,379 | +8.3% | 0.00% | – |
| Q4 2016 | $36,000 | -99.9% | 5,889 | -0.3% | 0.00% | – |
| Q3 2016 | $42,221,000 | -1.5% | 5,905 | +0.2% | 0.00% | – |
| Q2 2016 | $42,864,000 | – | 5,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $38,944,000 | 2.95% |
| NEA Management Company, LLC | 9,089,041 | $48,081,000 | 2.27% |
| Camber Capital Management LP | 3,500,000 | $18,515,000 | 0.94% |
| Redmile Group, LLC | 1,343,845 | $7,109,000 | 0.17% |
| CAXTON CORP | 25,748 | $136,000 | 0.13% |
| Alambic Investment Management, L.P. | 15,210 | $80,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,120 | $366,000 | 0.06% |
| OXFORD ASSET MANAGEMENT LLP | 133,008 | $704,000 | 0.02% |
| AXA S.A. | 1,890,492 | $10,002,000 | 0.02% |
| Athanor Capital, LP | 59,572 | $315,000 | 0.01% |